319 related articles for article (PubMed ID: 2026886)
1. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
Karlhofer FM; Yokoyama WM
J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886
[TBL] [Abstract][Full Text] [Related]
2. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro.
Kung SK; Miller RG
J Immunol; 1995 Feb; 154(4):1624-33. PubMed ID: 7836747
[TBL] [Abstract][Full Text] [Related]
3. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
Morelli L; Lemieux S
J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
[TBL] [Abstract][Full Text] [Related]
4. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
[TBL] [Abstract][Full Text] [Related]
6. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
Wang M; Ellison CA; Gartner JG; HayGlass KT
J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
[TBL] [Abstract][Full Text] [Related]
8. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
9. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
[TBL] [Abstract][Full Text] [Related]
10. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
[TBL] [Abstract][Full Text] [Related]
12. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
13. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
[TBL] [Abstract][Full Text] [Related]
14. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.
Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F
J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
Ballas ZK; Rasmussen W
J Immunol; 1990 Jan; 144(1):386-95. PubMed ID: 2104892
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
19. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
Kim S; Yokoyama WM
Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
[TBL] [Abstract][Full Text] [Related]
20. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
